Rosuvastatin & Fenofibrate Tablets IP
Rosuvastatin 10 mg + Fenofibrate 160 mg
A tablet formulation containing
10 × 10 Tablets
Film Coated Tablets
10 mg
160 mg
10 × 10 Tablets
Film Coated Tablets
| Ingredient | Amount per Serving |
|---|---|
| Rosuvastatin Calcium IP | Equivalent to Rosuvastatin 10 mg |
| Fenofibrate (Micronized) IP | 160 mg |
| Excipients | q.s. |
| Colours | Titanium Dioxide IP & Lake Sunset Yellow FCF |
Rosuvastatin Calcium IP, equivalent to Rosuvastatin 10 mg
ROVASNI-F is presented as film coated tablets in blister strips. The pack is labelled as 10 × 10 tablets, providing 10 tablets per strip and a total pack presentation of 100 tablets.
10 Tablets
10 × 10 Tablets
As directed by the Physician.
Store at a temperature not exceeding 30°C. Protect from light and moisture.
Keep out of reach of children.
SCHEDULE H PRESCRIPTION DRUG — CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
ROVASNI-F is a prescription medicine presented as film coated tablets containing Rosuvastatin Calcium IP equivalent to Rosuvastatin 10 mg and Fenofibrate (Micronized) IP 160 mg.
Each film coated tablet contains Rosuvastatin Calcium IP equivalent to Rosuvastatin 10 mg and Fenofibrate (Micronized) IP 160 mg. It also contains excipients q.s. and the colours Titanium Dioxide IP and Lake Sunset Yellow FCF.
ROVASNI-F is labelled as a 10 × 10 Tablets pack, with 10 tablets per blister strip.
The dosage should be followed strictly as directed by the physician.
Store at a temperature not exceeding 30°C and protect from light and moisture. Keep out of reach of children.
Yes. ROVASNI-F is labelled as a Schedule H prescription drug and is not to be sold by retail without the prescription of a Registered Medical Practitioner.
ROVASNI-F is manufactured by Lifevision Healthcare, a WHO-GMP Certified Company.